Causes and management of diarrhoea in children in a clinical setting

dc.contributor.authorCooke M.L.
dc.date.accessioned2011-05-15T15:57:34Z
dc.date.available2011-05-15T15:57:34Z
dc.date.issued2010
dc.description.abstractDiarrhoeal disease and its complications remain a major cause of morbidity and mortality in children, especially in developing countries. Diarrhoea is characterised by an increased frequency and volume, and decreased consistency of stool from the norm. Pathogens vary between developed and developing world settings. Rotavirus diarrhoea is the most important aetiological agent implicated in severe dehydrating diarrhoea. Although it is important to recognise the specific microbiological causation of diarrhoea in order to target appropriate treatment, the broader preventive aspects put forward by the World Health Organization (WHO) indicate the fundamental contributors to the massive burden of disease in developing countries. The management of a child presenting with acute diarrhoea must include a thorough history and examination with evaluation of hydration status, nutritional status and comprehensive clinical evaluation for any complications or associated illnesses. The most recent advances in the area of acute diarrhoeal disease include zinc supplementation, reduced osmolarity oral rehydration solution (ORS) and rotavirus vaccination.
dc.description.versionReview
dc.identifier.citationSouth African Journal of Clinical Nutrition
dc.identifier.citation23
dc.identifier.citation1 SUPPL.
dc.identifier.issn16070658
dc.identifier.urihttp://hdl.handle.net/10019.1/10480
dc.subjectampicillin
dc.subjectbicarbonate
dc.subjectceftriaxone
dc.subjectdoxycycline
dc.subjecterythromycin
dc.subjectgentamicin
dc.subjectmetronidazole
dc.subjectnalidixic acid
dc.subjectondansetron
dc.subjectoral rehydration solution
dc.subjectprobiotic agent
dc.subjectquinoline derived antiinfective agent
dc.subjectRotavirus vaccine
dc.subjecttrace element
dc.subjectvancomycin
dc.subjectzinc
dc.subjectacute diarrhea
dc.subjectAdenovirus
dc.subjectamebiasis
dc.subjectAstrovirus
dc.subjectbacterial infection
dc.subjectCalicivirus
dc.subjectCampylobacter jejuni
dc.subjectcholera
dc.subjectchronic diarrhea
dc.subjectclinical evaluation
dc.subjectClostridium difficile infection
dc.subjectCryptosporidium parvum
dc.subjectdehydration
dc.subjectdeveloping country
dc.subjectdiarrhea
dc.subjectdiet supplementation
dc.subjectdisease severity
dc.subjectdysentery
dc.subjectEntamoeba histolytica
dc.subjectEnterovirus
dc.subjectEscherichia coli
dc.subjectgastroenteritis
dc.subjectGiardia lamblia
dc.subjectgiardiasis
dc.subjecthuman
dc.subjecthypovolemic shock
dc.subjectmorbidity
dc.subjectmortality
dc.subjectNorovirus
dc.subjectnutritional status
dc.subjectoral rehydration therapy
dc.subjectpediatrics
dc.subjectreview
dc.subjectRotavirus
dc.subjectSalmonella
dc.subjectShiga toxin producing Escherichia coli
dc.subjectShigella
dc.subjecttreatment indication
dc.subjectvaccination
dc.subjectVibrio cholerae
dc.subjectvomiting
dc.subjectworld health organization
dc.subjectzinc deficiency
dc.subjectRotavirus
dc.titleCauses and management of diarrhoea in children in a clinical setting
dc.typeReview
Files